SUBSTITUTED PYRIDINE DERIVATIVES USEFUL AS GSK-3 INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:EP3066092A1
公开(公告)日:2016-09-14
Substituted Pyridine Derivatives Useful as GSK-3 Inhibitors
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20160289210A1
公开(公告)日:2016-10-06
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, antagonists of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.